#pharmaceutical-pollution

Waste from pharmaceutical manufacturing, healthcare, households, farms and sewage systems releases antibiotics, resistant bacteria and resistance genes into environmental reservoirs.

Keep unused medicines, contaminated manure, healthcare waste and treatment sludge out of uncontrolled drains, fields and dumps through collection, treatment and risk-based reuse rules.

Use ozonation, activated carbon, advanced oxidation, membranes, or source-specific pretreatment at high-risk facilities after effective conventional treatment, with monitoring of antibiotic residues, resistant bacteria, resistance genes, and treatment by-products.

Set enforceable antibiotic-residue limits for manufacturing wastewater and solid waste, require monitoring and audits, and make compliance part of procurement and regulatory approval.

The Neugut wastewater treatment plant near Zurich was Switzerland's first full-scale municipal ozonation installation. Researchers sampled effluent at three stages — conventional treatment, ozone treatment, and biologic…

In January 2020, India published draft environmental rules proposing concentration limits for residues of 121 antibiotics in treated effluent from bulk-drug and formulation facilities — a proposal that would have create…